Sagimet Biosciences Inc.
SGMT
$2.21
$0.199.41%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -0.81% | -8.35% | -14.11% | 104.12% | -6.82% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -75.31% | 1,632.66% | -63.42% | -49.85% | 50.72% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 13.76% | 213.08% | 20.37% | -72.80% | 415.58% |
Total Current Assets | -2.81% | -5.73% | -14.26% | 101.24% | -6.00% |
|
|||||
Total Current Assets | -2.81% | -5.73% | -14.26% | 101.24% | -6.00% |
Net Property, Plant & Equipment | -32.46% | -24.50% | 308.11% | -49.32% | -33.03% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -8.31% | -7.54% | -2.83% | 101.13% | -6.03% |
|
|||||
Total Accounts Payable | 23.70% | -42.23% | 275.52% | 185.48% | -89.07% |
Total Accrued Expenses | 4.73% | -21.23% | -9.66% | -18.44% | 53.92% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -32.76% | -24.18% | 488.46% | -60.00% | -36.89% |
Total Finance Division Other Current Liabilities | -54.55% | 10.00% | -- | -- | 485.26% |
Total Other Current Liabilities | -54.55% | 10.00% | -- | -- | 485.26% |
Total Current Liabilities | 8.85% | -28.56% | 27.01% | -20.23% | 11.98% |
|
|||||
Total Current Liabilities | 8.85% | -28.56% | 27.01% | -20.23% | 11.98% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 8.85% | -28.56% | 27.01% | -20.23% | 11.96% |
|
|||||
Common Stock & APIC | 0.34% | 0.35% | 0.32% | 30.99% | 0.39% |
Retained Earnings | -5.80% | -5.53% | -3.17% | -2.65% | -3.37% |
Treasury Stock & Other | -47.85% | 2,017.39% | -428.57% | -76.67% | -- |
Total Common Equity | -8.72% | -6.88% | -3.54% | 108.66% | -6.96% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -8.72% | -6.88% | -3.54% | 108.66% | -6.96% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -8.72% | -6.88% | -3.54% | 108.66% | -6.96% |
|